Mechanisms causing muscle loss in chronic renal failure
- PMID: 7611258
- DOI: 10.1016/0272-6386(95)90179-5
Mechanisms causing muscle loss in chronic renal failure
Abstract
The loss of lean body mass in uremia is associated with excessive morbidity and mortality. A potential mechanism causing protein catabolism is that uremia overcomes critical metabolic responses required to maintain protein balance whenever dietary protein is limited. These responses include reduced oxidation of essential amino acids, which improves the efficiency of protein utilization and a reduction in protein degradation. We find that metabolic acidosis stimulates both amino acid oxidation and protein degradation in muscle and thus could overcome the adaptive responses. The molecular mechanisms stimulating catabolism involve glucocorticoids and includes increased mRNAs of components of catabolic pathways. Studies in patients have confirmed that acidosis causes catabolism in chronic renal failure. Thus, we recommend that patients with metabolic acidosis receive an adequate diet and sufficient alkali to correct acidosis.
Similar articles
-
Metabolic acidosis stimulates protein metabolism in uremia.Miner Electrolyte Metab. 1996;22(1-3):62-5. Miner Electrolyte Metab. 1996. PMID: 8676827 Review.
-
Cellular mechanisms of catabolism activated by metabolic acidosis.Blood Purif. 1995 Nov-Dec;13(6):368-74. doi: 10.1159/000170223. Blood Purif. 1995. PMID: 8821202 Review.
-
Low-protein diets in the treatment of chronic renal failure.J Am Coll Nutr. 1995 Aug;14(4):311-6. doi: 10.1080/07315724.1995.10718515. J Am Coll Nutr. 1995. PMID: 8568106 Review.
-
Mechanisms for protein catabolism in uremia: metabolic acidosis and activation of proteolytic pathways.Miner Electrolyte Metab. 1992;18(2-5):233-6. Miner Electrolyte Metab. 1992. PMID: 1465065 Review.
-
Metabolic consequences of uremia: extending the concept of adaptive responses to protein metabolism.Am J Kidney Dis. 1994 Feb;23(2):224-8. doi: 10.1016/s0272-6386(12)80976-0. Am J Kidney Dis. 1994. PMID: 8311079 Review.
Cited by
-
Association of cystatin C kidney function measures with motoric cognitive risk syndrome: evidence from two cohort studies.J Nutr Health Aging. 2025 Mar;29(3):100484. doi: 10.1016/j.jnha.2025.100484. Epub 2025 Jan 9. J Nutr Health Aging. 2025. PMID: 39793439 Free PMC article.
-
Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease.Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1108-E1120. doi: 10.1152/ajpendo.00070.2018. Epub 2018 Jun 12. Am J Physiol Endocrinol Metab. 2018. PMID: 29894202 Free PMC article. Clinical Trial.
-
-374 T/A RAGE polymorphism is associated with chronic kidney disease progression in subjects affected by nephrocardiovascular disease.PLoS One. 2013 Apr 4;8(4):e60089. doi: 10.1371/journal.pone.0060089. Print 2013. PLoS One. 2013. PMID: 23593165 Free PMC article.
-
Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study.J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):301-7. doi: 10.1093/gerona/glt096. Epub 2013 Aug 2. J Gerontol A Biol Sci Med Sci. 2014. PMID: 23913929 Free PMC article.
-
Protein-energy wasting and mortality in chronic kidney disease.Int J Environ Res Public Health. 2011 May;8(5):1631-54. doi: 10.3390/ijerph8051631. Epub 2011 May 19. Int J Environ Res Public Health. 2011. PMID: 21655142 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical